Top brokers name 3 ASX shares to buy next week

Telstra Corporation Ltd (ASX:TLS) shares are one of three that brokers have tipped as buys this week…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market selloff last week was disappointing, but one positive is that it has created a number of buying opportunities for investors.

Three shares that top brokers think are in the buy zone are listed below. Here's why they are bullish on them:

Fortescue Metals Group Limited (ASX: FMG)

According to a note out of Credit Suisse, it has retained its outperform rating and $5.50 price target on this iron ore producer's shares. The broker appears pleased that Fortescue's $500 million on-market share buyback has the potential to be accretive to earnings in FY 2019. It expects this to support its share price and stop it from drifting lower. In addition to this, Credit Suisse believes that Fortescue's shares offer a lot of long-term value for investors at current levels. While I do agree on a lot of this, I'd like to see the discount on its low grade ore reduce before investing.

Ramsay Health Care Limited (ASX: RHC)

Analysts at Citi have retained their buy rating and $62.00 price target on this private hospital operator's shares after its takeover target, Capio, recommended Ramsay's offer. Citi seems happy that this acquisition will mean an expansion into the German and Scandinavian markets. It also sees synergy opportunities for its France-based hospitals. I would agree that this is a good acquisition by Ramsay. However, with its key Australian business continuing to struggle, I intend to stay away from Ramsay until its shares trade on a fairer multiple or its performance at home improves.

Telstra Corporation Ltd (ASX: TLS)

A note out of Goldman Sachs reveals that its analysts have held firm with their conviction buy rating and $3.60 price target on this telco giant's shares following the release of its executive remuneration update. The broker appears pleased with the remuneration plan which includes quantitative targets for the first time. These include plan simplification targets and digital sales. Telstra aims to cut its plan numbers down significantly and is targeting digital sales of 45% by FY 2022, compared to 6.2% in FY 2018. I think Telstra does look attractive at these levels and could be worth a look. Though, it may be prudent to wait for its first half results and confirmation of its full year dividend.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »